INSIGHTS ON CLINICAL TRIAL DESIGN
-
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove A Drug Works
PTSD trials expose one of the hardest problems in modern drug development, a reliance on clinician-administered and patient-reported scales to determine whether a therapy truly works.
-
How Community Engagement Drives Better Study Outcomes
Examples of how embedded community sites and local events show how authentic on‑the‑ground involvement translates into deeper patient relationships and measurable study outcomes.
-
Can Patient Liaison Services Transform Clinical Research Access?
Patients often face invisible hurdles in research. Watch how Patient Liaison services can change the journey for participants, sites, and sponsors, making trials easier to join and stay in.
-
Flexible Supply Strategies For Complex Clinical Trials
Explore how demand-led, decentralized clinical supply models are reshaping complex trials by reducing waste, accelerating timelines, and advancing patient-centric access to investigational therapies.
-
Biotech Landscape Continues To Shift9/18/2025
Global shifts are adding new layers of challenge and opportunity for the biotech sector, as companies navigate a period of unprecedented complexity.
-
Investigational Insights: Elevating IDS Practice Through Continuing Education6/10/2026
Discover how leading IDS teams are using automation and standardized digital workflows to streamline protocol management, reduce errors, improve efficiency, and strengthen research operations.
-
Driving Diversification And Reach With Tech In Community DCTs3/20/2025
Learn how technology, when used correctly, can accelerate trial timelines and drive patient diversification in community-based decentralized clinical trials (DCTs).
-
Best Practices In Rare Disease Patient Recruitment3/9/2026
Recruiting for rare disease clinical trials is daunting, and making patients aware of clinical trials, involving them in trial design, and building trust are a few ways sponsors can boost recruitment.
-
From Hype To Health: How Sword Built Evidence That Scales8/19/2026
A candid look at balancing resource constraints with rigorous clinical strategy to earn trust, reimbursement, and real growth.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Flow cytometry is a foundational tool in modern drug development, and its application in receptor occupancy assays has become essential for evaluating therapeutic engagement with disease targets.
-
CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.
-
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.
-
Avance Clinical has located its Asia hub operations in Seoul, South Korea which is highly regarded for its advanced technology and scientific and medical excellence.
-
Block Clinical provides a single point of contact for Patients and Sites who support them throughout their journey, from start to finish.